摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-methylthio-2,5-dihydro-thiazole | 623564-70-5

中文名称
——
中文别名
——
英文名称
4-methylthio-2,5-dihydro-thiazole
英文别名
4-(Methylthio)-2,5-dihydrothiazole;4-methylsulfanyl-2,5-dihydro-1,3-thiazole
4-methylthio-2,5-dihydro-thiazole化学式
CAS
623564-70-5
化学式
C4H7NS2
mdl
——
分子量
133.238
InChiKey
NFSOPDQHRACHRD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    223.2±33.0 °C(Predicted)
  • 密度:
    1.32±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    7
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    63
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    4-methylthio-2,5-dihydro-thiazole 在 ammonium chloride 、 potassium carbonate 作用下, 以 乙醇氯仿 为溶剂, 生成 2,5-二氢-1,3-噻唑-4-胺
    参考文献:
    名称:
    Process for preparing 6-alkylidene penem derivatives
    摘要:
    本发明提供了一种制备式I化合物的方法,该化合物对治疗细菌感染或疾病有用。
    公开号:
    US20040132708A1
  • 作为产物:
    描述:
    1,3-噻唑烷-4-硫酮碘甲烷氯仿 为溶剂, 反应 7.5h, 以100%的产率得到4-methylthio-2,5-dihydro-thiazole
    参考文献:
    名称:
    [EN] BICYCLIC 6-ALKYLIDENE-PENEMS AS ß-LACTAMASES INHIBITORS
    [FR] PENEMES 6-ALKYLIDENE BICYCLIQUES UTILISES EN TANT QU'INHIBITEURS DE ss-LACTAMASES
    摘要:
    本发明提供了一种化合物(I)的配方、药物组合物以及其用于治疗患有细菌感染或疾病的患者的用途。
    公开号:
    WO2003093279A1
点击查看最新优质反应信息

文献信息

  • Bicyclic 6-alkylidene-penems as class-D beta-lactamases inhibitors
    申请人:Mansour Suhayl Tarek
    公开号:US20060276445A1
    公开(公告)日:2006-12-07
    This invention relates to certain bicyclic 6-alkylidene penems which act as a inhibitor of class-D enzymes. β-Lactamases hydrolyze β-lactam antibiotics, and as such serve as the primary cause of bacterial resistance. The compounds of the present invention when combined with β-lactam antibiotics will provide an effective treatment against life threatening bacterial infections. In accordance with the present invention there are provided compounds of general formula I or a pharmaceutically acceptable salt or in vivo hydrolyzable ester R 5 thereof: wherein: One of A and B denotes hydrogen and the other an optionally substituted fused bicyclic heteroaryl group; and X═O or S.
    这项发明涉及某些具有双环6-烷基亚烯基青霉素结构的化合物,其作为D类酶的抑制剂。β-内酰胺酶水解β-内酰胺类抗生素,因此是细菌耐药的主要原因。本发明的化合物与β-内酰胺类抗生素结合后,将提供一种有效的治疗方法,用于治疗威胁生命的细菌感染。根据本发明,提供了一般式I的化合物,或其药学上可接受的盐或体内可水解的酯R5:其中:A和B中的一个表示氢,另一个表示可选择取代的融合双环杂环芳基团;X=O或S。
  • [EN] PROCESS FOR PREPARING 6-ALKYLIDENE PENEM DERIVATIVES<br/>[FR] PROCEDE DE PREPARATION DE DERIVES DE 6-ALKYLIDENE PENEM
    申请人:WYETH CORP
    公开号:WO2003093277A1
    公开(公告)日:2003-11-13
    The present invention provides a process of making compounds of Formula (I), which are useful for the treatment of bacterial infection or disease.
    本发明提供了一种制备化合物的方法,该化合物符合式(I),对于治疗细菌感染或疾病非常有用。
  • Process for preparing 6-alkylidene penem derivatives
    申请人:Wyeth
    公开号:US20040132708A1
    公开(公告)日:2004-07-08
    The present invention provides a process of making compounds of formula I, which are useful for the treatment of bacterial infection or disease. 1
    本发明提供了一种制备式I化合物的方法,该化合物对治疗细菌感染或疾病有用。
  • [EN] BICYCLIC 6-ALKYLIDENE-PENEMS AS ß-LACTAMASES INHIBITORS<br/>[FR] PENEMES 6-ALKYLIDENE BICYCLIQUES UTILISES EN TANT QU'INHIBITEURS DE ss-LACTAMASES
    申请人:WYETH CORP
    公开号:WO2003093279A1
    公开(公告)日:2003-11-13
    The present invention provides a compound of Formula (I), pharmaceutical compositions and the use thereof for the treatment of bacterial infection or disease in a patient in need thereof.
    本发明提供了一种化合物(I)的配方、药物组合物以及其用于治疗患有细菌感染或疾病的患者的用途。
查看更多

同类化合物

替莫美他汀 乙酰亚胺基硫酸,甲基酯 5-甲基四氢噻吩-2-亚胺盐酸盐 4-[(1E,5E,7E,11R)-11-甲氧基十四碳-1,5,7,13-四烯基]-2-(2-甲基环丙基)-4,5-二氢-1,3-噻唑 2-环戊基-4,5-二氢-1,3-噻唑 2-氧代丙基乙烷硫代亚氨酸酯 2-亚氨基硫烷盐酸盐 2-亚氨基硫杂环戊烷 2-亚氨基-5-甲基-3-(3-氧代丁基)四氢-3-噻吩甲腈 2-亚氨基-4-氧代四氢-3-噻吩羧酸 2-亚氨基-2-(甲基硫代)乙酸乙酯 2-亚氨基-2,3-二氢-噻吩 1-[5-(甲硫基)-3,4-二氢-2H-吡咯-3-基]乙酮 (S)-5-乙基-2-硫代甲基-1-吡咯啉 (4R)-4-[(1Z,5E,7E,11R)-11-甲氧基-8-甲基十四碳-1,5,7,13-四烯基]-2-[(1R,2S)-2-甲基环丙基]-4,5-二氢-1,3-噻唑 (3,6-二碘噻吩并[3,2-b]噻吩e-2,5-二亚基)二氰胺 ethyl [2-(tiophen-2-yl)-4,5-dihydrothiazol-5-yl]acetate 6-amino-3-carbamoyl-2-carbethoxymethylthio-5-cyano-3,4-dihydrospirocyclohexane-4-pyridine 2-allylthio-6-amino-3-carbamoyl-5-cyano-3,4-dihydrospirocyclohexane-4-pyridine N-<1-(4,5-Dihydro-1,3-thiazol-2-yl)cyclopentyl>-N',N'-dimethylthioharnstoff 2-methylthio-4'-oxo-5,5-pentamethylenespiro[1'-pyrroline-3,1'-cyclohexadiene] 2',6'-dimethoxy-5,5-dimethyl-2-methylthio-4'-oxospiro(1-pyrrolin-3,1'-cyclohexadiene) 2-(methylthio)-1-azetine 2-imino-tetrahydro-thiophene-3-carboxylic acid ethyl ester 4-Methyl-N-(2-vinyloxy-ethyl)-penta-2,3-dienimidothioic acid methyl ester N-ethyl-2-ethylsulfanyl-1-methylsulfanyl-2-propen-1-imine 8-(ethylthio)-6-methyl-7-azabicyclo<4.2.0>octa-3,7-diene 3,3,7-trimethyl-1-methylthio-2-azaspiro[4.5]deca-1,6,9-trien-8-one 1,1-dimethyl-4-methylsulfanyl-1,5-diazapentadiene hydriodide N-methyl-2-ethoxy-1-methylsulfanyl-2-propen-1-imine 7-hydroxy-6,9-dimethoxy-3-methyl-1-methylsulfanyl-2-azaspiro[4.5]deca-1,6,9-trien-8-one 19S-curacin A 15,16-dihydrocuracin A curacin B 2-Methoxy-N-(2-vinyloxy-ethyl)-buta-2,3-dienimidothioic acid methyl ester N-methyl-2-ethylsulfanyl-1-methylsulfanyl-2-propen-1-imine N-(tert-Butoxycarbonyl)-glycyl-glycin-imidthiosaeure-S-ethylester Methyl propanimidothioate;hydrochloride 2,2-dimethyl-4-methylthio-3-thiazoline methyl 2-methoxy-N-methyl-2,3-butadienimidothioate 4-(2-bromopropan-2-yl)-4,5-dihydro-2,4'-bithiazole 2-(Cyclopropyl)-2-thiazolin 5.5'-Dimethyl-2.2'-bi-2-thiazolin 4-chloromethyl-2-thiophen-2-yl-4,5-dihydro-thiazol-4-ol 5,5-dimethyl-2-iminothiolane hydrochloride N-(3-methyl-2-thietanylidene)isopropylamine Aethyl-N-vinylformimidat thioacetimidic acid butyl ester; hydrochloride tert-butyl (4S)-4-[(4S)-4-cyano-4-methyl-5H-1,3-thiazol-2-yl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate Ethyl-thioacetamidat